These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 25787989)
1. Interventions to combat or prevent drug counterfeiting: a systematic review. El-Jardali F; Akl EA; Fadlallah R; Oliver S; Saleh N; El-Bawab L; Rizk R; Farha A; Hamra R BMJ Open; 2015 Mar; 5(3):e006290. PubMed ID: 25787989 [TBL] [Abstract][Full Text] [Related]
2. Strategies and Systems-Level Interventions to Combat or Prevent Drug Counterfeiting: A Systematic Review of Evidence Beyond Effectiveness. Fadlallah R; El-Jardali F; Annan F; Azzam H; Akl EA Pharmaceut Med; 2016; 30(5):263-276. PubMed ID: 27752221 [TBL] [Abstract][Full Text] [Related]
3. Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries. Tadeg H; Berhane Y East Afr J Public Health; 2012 Jun; 9(2):85-9. PubMed ID: 23139963 [TBL] [Abstract][Full Text] [Related]
4. Counterfeit pharmaceuticals: current status and future projections. Wertheimer AI; Chaney NM; Santella T J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268 [TBL] [Abstract][Full Text] [Related]
5. Substandard and counterfeit medicines: a systematic review of the literature. Almuzaini T; Choonara I; Sammons H BMJ Open; 2013 Aug; 3(8):e002923. PubMed ID: 23955188 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. Ozawa S; Evans DR; Bessias S; Haynie DG; Yemeke TT; Laing SK; Herrington JE JAMA Netw Open; 2018 Aug; 1(4):e181662. PubMed ID: 30646106 [TBL] [Abstract][Full Text] [Related]
7. Fighting trafficking of falsified and substandard medicinal products in Russia. Fayzrakhmanov NF Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702 [TBL] [Abstract][Full Text] [Related]
8. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy. Nsimba SE East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325 [TBL] [Abstract][Full Text] [Related]
9. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies. Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827 [TBL] [Abstract][Full Text] [Related]
10. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review. Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611 [TBL] [Abstract][Full Text] [Related]
11. Public Health Implications of Counterfeit Medications. Fantasia HC; Vooys KM Nurs Womens Health; 2018 Jun; 22(3):264-268. PubMed ID: 29885715 [TBL] [Abstract][Full Text] [Related]
12. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect? Allen D; Rixson L Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815 [TBL] [Abstract][Full Text] [Related]
13. [Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data]. Amato L; Colais P; Davoli M; Ferroni E; Fusco D; Minozzi S; Moirano F; Sciattella P; Vecchi S; Ventura M; Perucci CA Epidemiol Prev; 2013; 37(2-3 Suppl 2):1-100. PubMed ID: 23851286 [TBL] [Abstract][Full Text] [Related]
14. Weight loss interventions for chronic asthma. Adeniyi FB; Young T Cochrane Database Syst Rev; 2012 Jul; (7):CD009339. PubMed ID: 22786526 [TBL] [Abstract][Full Text] [Related]
15. Poor-Quality and Counterfeit Drugs: A Systematic Assessment of Prevalence and Risks Based on Data Published From 2007 to 2016. Koczwara A; Dressman J J Pharm Sci; 2017 Oct; 106(10):2921-2929. PubMed ID: 28549909 [TBL] [Abstract][Full Text] [Related]
16. Fake medicines are everybody's business. Benton D; Williamson L Aust Nurs Midwifery J; 2014 May; 21(10):26. PubMed ID: 24941562 [No Abstract] [Full Text] [Related]